🎯 check BI-10773 (Empagliflozin) product page
BI-10773 (Empagliflozin) is a potent, highly selective SGLT2 inhibitor. It affects renal glucose reabsorption pathways by competitively blocking the sodium-glucose co-transporter 2 in the proximal tubule, promoting urinary glucose excretion and lowering blood glucose levels.